Literature DB >> 32314595

Postpericardiotomy syndrome after cardiac surgery.

Joonas Lehto1, Tuomas Kiviniemi1,2.   

Abstract

Postpericardiotomy syndrome (PPS) is a well-known complication after cardiac surgery. The syndrome results in prolonged hospital stay, readmissions, and invasive interventions. Previous studies have reported inconsistent results concerning the incidence and risk factors for PPS due to the differences in the applied diagnostic criteria, study designs, patient populations, and procedure types. In recent prospective studies the reported incidences have been between 21 and 29% in adult cardiac surgery patients. However, it has been stated that most of the included diagnoses in the aforementioned studies would be clinically irrelevant. This challenges the specificity and usability of the currently recommended diagnostic criteria for PPS. Moreover, recent evidence suggests that PPS requiring invasive intervention such as the evacuation of pleural and/or pericardial effusion is associated with increased mortality. In the present review, we summarise the existing literature concerning the incidence, clinical features, diagnostic criteria, risk factors, management, and prognosis of PPS. We also propose novel approaches regarding to the definition and diagnosis of PPS. Key messages: Current diagnostic criteria of PPS should be reconsidered, and the analyses should be divided into subgroups according to the severity of the syndrome to achieve more clinically applicable and meaningful results in the future studies. In contrast with the previous presumption, severe PPS - defined as PPS requiring invasive interventions - was recently found to be associated with higher all-cause mortality during the first two years after cardiac surgery. The association with an increased mortality supports the use of relatively aggressive prophylactic methods to prevent PPS. The risk factors clearly increasing the occurrence of PPS are younger age, pleural incision, and valve and ascending aortic procedures when compared to CABG.

Entities:  

Keywords:  Postpericardiotomy syndrome; adverse events; cardiac surgery; clinical features; diagnostic criteria; epidemiology; pericardium; prognosis; risk factors; treatment

Year:  2020        PMID: 32314595      PMCID: PMC7877990          DOI: 10.1080/07853890.2020.1758339

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  165 in total

Review 1.  Repeated postpericardiotomy syndrome following a temporary transvenous pacemaker insertion, a permanent transvenous pacemaker insertion and surgical pericardiotomy.

Authors:  A Sasaki; H Kobayashi; T Okubo; Y Namatame; A Yamashina
Journal:  Jpn Circ J       Date:  2001-04

2.  THE POSTPERICARDIOTOMY SYNDROME: A SIX-YEAR EPIDEMIOLOGIC STUDY.

Authors:  L M DRUSIN; M A ENGLE; J W HAGSTROM; M S SCHWARTZ
Journal:  N Engl J Med       Date:  1965-03-25       Impact factor: 91.245

3.  Postpericardiotomy syndrome: no evidence for a viral etiology.

Authors:  S A Webber; N J Wilson; A K Junker; S K Byrne; A Perry; E E Thomas; L Book; M Tipple; M W Patterson; G G Sandor
Journal:  Cardiol Young       Date:  2001-01       Impact factor: 1.093

4.  Post-cardiac injury syndrome after permanent electronic cardiac device implantation. Incidence, presentation, management and long-term prognosis.

Authors:  Konstantinos Gatzoulis; Stefanos Archontakis; Dimitrios Tsiachris; George Lazaros; Theodoros Apostolopoulos; George Zervopoulos; Xenofon Costeas; Polychronis Dilaveris; Skevos Sideris; Ioannis Kallikazaros; Christodoulos Stefanadis
Journal:  Int J Cardiol       Date:  2014-04-02       Impact factor: 4.164

5.  Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane.

Authors:  F Paronetto; H Popper
Journal:  N Engl J Med       Date:  1970-08-06       Impact factor: 91.245

6.  Behavior of inflammatory markers of myocardial injury in cardiac surgery: laboratory correlation with the clinical picture of postpericardiotomy syndrome.

Authors:  Ilmar Köhler; Paulo J Saraiva; Orlando B Wender; Alcides J Zago
Journal:  Arq Bras Cardiol       Date:  2003-10-09       Impact factor: 2.000

7.  Constrictive pericarditis as a complication of cardiac surgery: recognition of an entity.

Authors:  M A Kutcher; S B King; B N Alimurung; J M Craver; R B Logue
Journal:  Am J Cardiol       Date:  1982-10       Impact factor: 2.778

8.  The significance of anticardiolipin antibodies and anti-heart muscle antibodies for the diagnosis of postpericardiotomy syndrome.

Authors:  C Bartels; R Hönig; G Burger; V Diehl; R de Vivie
Journal:  Eur Heart J       Date:  1994-11       Impact factor: 29.983

9.  Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis.

Authors:  Michele Moretti; Alessandra Buiatti; Marco Merlo; Laura Massa; Enrico Fabris; Bruno Pinamonti; Gianfranco Sinagra
Journal:  Am J Cardiol       Date:  2013-08-22       Impact factor: 2.778

10.  Low interleukin-8 level predicts the occurrence of the postpericardiotomy syndrome.

Authors:  Maria Jaworska-Wilczyńska; Adriana Magalska; Katarzyna Piwocka; Piotr Szymański; Mariusz Kuśmierczyk; Maria Wąsik; Tomasz Hryniewiecki
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

View more
  3 in total

1.  Predictive value of NT-proBNP, procalcitonin and CVP in patients with new-onset postoperative atrial fibrillation after cardiac surgery.

Authors:  Zhiwei Xu; Long Qian; Lijuan Zhang; Yang Gao; Su Huang
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

Review 2.  Interleukin-1 Antagonists for the Treatment of Recurrent Pericarditis.

Authors:  Bryan Q Abadie; Paul C Cremer
Journal:  BioDrugs       Date:  2022-05-31       Impact factor: 7.744

3.  Autoimmune Disease Classification Based on PubMed Text Mining.

Authors:  Hadas Samuels; Malki Malov; Trishna Saha Detroja; Karin Ben Zaken; Naamah Bloch; Meital Gal-Tanamy; Orly Avni; Baruh Polis; Abraham O Samson
Journal:  J Clin Med       Date:  2022-07-26       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.